Terrence C. Kearney

Chief Financial Officer, Hospira.

Companies

Vertex PharmaceuticalsBoard member May 18, 2011 to May 3, 2024¹
Acceleron PharmaBoard member Jul 16, 2014 to Nov 22, 2021²
Innoviva, Inc.Board member Nov 3, 2014 to Apr 27, 2015³
HospiraChief operating officer May 19, 2006 to Dec 17, 2010⁴
HospiraChief financial officer May 19, 2006 to Jun 20, 2006⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vertex Pharmaceuticals VRTX6,536 shares⁵$3.3M at $499.29Aug 10, 2023
Acceleron Pharma XLRN0 shares⁶Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 10, 2023Sold 10,000 shares at $350.00 of Vertex Pharmaceuticals⁵
Aug 10, 2023Exercised options 10,000 shares at $127.54 of Vertex Pharmaceuticals⁵
May 1, 2022Granted 725 shares of Vertex Pharmaceuticals⁷
Nov 19, 2021U 6,749 shares of Acceleron Pharma⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVertex Pharmaceuticals, Board member
2
SEC EDGARAcceleron Pharma, Board member
3
SEC EDGARInnoviva, Inc., Board member
4
SEC EDGARHospira, Chief operating officer
5
SEC EDGARVertex Pharmaceuticals shares after the filing of Aug 10, 2023
6
SEC EDGARAcceleron Pharma shares after the filing of Nov 19, 2021
7
SEC EDGARForm 4 filed May 3, 2022